A 3D microfluidic printing platform for complex human tissues used in the next generation of regenerative therapies.
We partnered with Aspect’s technology and product teams to define a data strategy and AI roadmap to improve quality control and tissue design.
Co-Founder & General Partner
Get our weekly email newsletter of curated insights and AI news.
© 2022 Radical Ventures Investments Inc.